Pediatrics

FDA Approves Treatment for C. difficile in Kids




The FDA has expanded approval of the macrolide antibiotic fidaxomicin (brand name, Dificid) to treat Clostridioides difficile–associated diarrhea in children aged 6 months and…

Source link






Related posts

The 2018 Joseph W. St. Geme, Jr. Leadership Award Address: Reflections on Mentorship

Newsemia

Many Young Juul Users May Not Know They’re Addicted

Newsemia

Prescription Opioid Misuse and Risky Adolescent Behavior

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy